INVITRO ACTIVITY OF THE NEW QUINOLINE DERIVATIVE CIPROFLOXACIN ALONE AND IN COMBINATION AGAINST VARIOUS MYCOBACTERIUM-COLI, SALMONELLA-COLI AND ESCHERICHIA-COLI STRAINS
- 1 January 1986
- journal article
- research article
- Vol. 36-1 (6) , 904-912
Abstract
The antibacterial effect of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazine-1-ylquinoline 3-carboxylic acid (ciprofloxacin, Bay o 9867) has been tested using different test systems and various strains, especially of Escherichia coli, Mycobacterium and Salmonella. Ciprofloxacin shows low MIC''s against most of the tested strains. The high in vitro and in vivo activity against Salmonella is most promising for cure of salmonellosis.This publication has 16 references indexed in Scilit:
- Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- Bacterial Growth Kinetics of Escherichia coli and Mycobacteria in the Presence of Brodimoprim and Metioprim Alone and in Combination with Sulfamerazine and Dapsone (VI)Chemotherapy, 1983
- BACTERIAL-GROWTH KINETICS OF M-LUFU IN THE PRESENCE AND ABSENCE OF VARIOUS DRUGS ALONE AND IN COMBINATION - A MODEL FOR THE DEVELOPMENT OF COMBINED CHEMOTHERAPY AGAINST MYCOBACTERIUM-LEPRAE1982
- STUDY OF UNCLASSIFIED DAPSONE SENSITIVE MYCOBACTERIA ISOLATED FROM THE ENVIRONMENT IN ZAIRE1980
- Comparison of Techniques for Measurement of in Vitro Antibiotic SynergismThe Journal of Infectious Diseases, 1979
- A Method for Testing for Synergy with Any Number of AgentsThe Journal of Infectious Diseases, 1978
- POLYCLONAL B-CELL ACTIVATION DURING RODENT MALARIAL INFECTIONS1978
- Treatment of Chronic Salmonella CarriersChemotherapy, 1977
- THE RELATION BETWEEN THE BINDING OF SULFONAMIDES TO ALBUMIN AND THEIR ANTIBACTERIAL EFFICACY1960